clear cell renal cell carcinoma
Showing NaN - NaN of 20
Clear Cell Renal Cell Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Lymph Nodes Trial in
Recruiting
- Clear Cell Renal Cell Carcinoma
- +6 more
- Cabozantinib
- +4 more
-
Anchorage, Alaska
- +828 more
Feb 2, 2023
Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)
Recruiting
- Clear Cell Renal Cell Carcinoma
- Belzutifan
- +2 more
-
Duarte, California
- +250 more
Jan 27, 2023
Advanced Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in United States (drug,
Recruiting
- Advanced Renal Cell Carcinoma
- +8 more
- Cabozantinib S-malate
- +3 more
-
Birmingham, Alabama
- +35 more
Jan 24, 2023
Clear Cell Renal Cell Carcinoma Trial in United States (Batiraxcept, Cabozantinib (Cabo), Nivolumab)
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- Batiraxcept
- +2 more
-
Baltimore, Maryland
- +16 more
Jan 17, 2023
Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)
Recruiting
- Clear Cell Renal Cell Carcinoma
-
Boston, Massachusetts
- +1 more
Dec 14, 2022
ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)
Recruiting
- ccRCC
- +9 more
- Oral NKT2152
-
Scottsdale, Arizona
- +6 more
Oct 17, 2022
Advanced Solid Tumor, Clear Cell Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Korea, Republic of, Singapore, United
Recruiting
- Advanced Solid Tumor
- +3 more
-
Duarte, California
- +22 more
Aug 17, 2022
Solid Tumor, Clear Cell Renal Cell Carcinoma, TNBC - Triple-Negative Breast Cancer Trial in United States (CB-839, Talazoparib)
Terminated
- Solid Tumor
- +6 more
-
Birmingham, Alabama
- +8 more
Feb 16, 2022
Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage II Renal Cell Cancer AJCC v7 Trial in Canada,
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Laboratory Biomarker Analysis
- +4 more
-
Birmingham, Alabama
- +986 more
Jan 13, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Boston (Stereotactic Body Radiotherapy (SBRT))
Terminated
- Ewing Sarcoma
- +10 more
- Stereotactic Body Radiotherapy (SBRT)
-
Boston, Massachusetts
- +2 more
Apr 5, 2021
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Completed
- Clear Cell Renal Cell Carcinoma
- +3 more
- Cabozantinib S-malate
- +2 more
-
Mobile, Alabama
- +487 more
Jan 28, 2021
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- Bevacizumab
- +3 more
-
Scottsdale, Arizona
- +523 more
Mar 5, 2019
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7 Trial in Peru, United States
Completed
- Clear Cell Renal Cell Carcinoma
- +2 more
- Bevacizumab
- +4 more
-
Birmingham, Alabama
- +558 more
Oct 15, 2018
Childhood Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Clear Cell Sarcoma of the Kidney Trial in Worldwide (drug,
Completed
- Childhood Renal Cell Carcinoma
- +12 more
- Doxorubicin Hydrochloride
- +9 more
-
Birmingham, Alabama
- +186 more
Jun 22, 2017
Chromophobe Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Trial in Boston, Philadelphia,
Completed
- Chromophobe Renal Cell Carcinoma
- +5 more
- Bevacizumab
- +3 more
-
Boston, Massachusetts
- +4 more
Jan 6, 2015
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014